3801 - 3810 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1539End Page: 1562Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00940-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00940-4.pdfCitation Count: 23
-
OPENTitle: If LRRK2 Set the Fire, Can Nonsteroidal Anti‐inflammatory Drugs Wet the Flames?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1727End Page: 1730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28240Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28240Citation Count: 4
- Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder alliance2020RESTRICTEDTitle: Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder allianceJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e89End Page: e90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.325Citation Count: 0
-
RESTRICTEDTitle: Impact of OFF periods on aspects of employment for people with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e89End Page: e89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.323Citation Count: 1
- Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson’s disease: 5 years and beyond2020OPENTitle: Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson’s disease: 5 years and beyondJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 135Issue #: 2Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2020.6.jns20617Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/aop/article-10.3171-2020.6.JNS20617/article-10.3171-2020.6.JNS20617.pdfCitation Count: 10
-
RESTRICTEDTitle: Management of Tardive Syndrome: Medications and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1694End Page: 1712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00898-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00898-3.pdfCitation Count: 15
-
RESTRICTEDTitle: Mechanisms behind Neurological Conditions Revealed, AdjustedJournal Name: Genetic Engineering & Biotechnology NewsPublisher: Mary Ann Liebert IncVol: 40Issue #: 10Start Page: 52, 54End Page: 56Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/gen.40.10.15Citation Count: 0
- Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci2020RESTRICTEDTitle: Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated lociJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 10Start Page: e0239824End Page: e0239824Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0239824Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0239824&type=printableCitation Count: 11
-
- Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention2020RESTRICTEDTitle: Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and RetentionJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1724End Page: 1735Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00960-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00960-0.pdfCitation Count: 37